Get started
Author

W. Weikel

Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
1998 · H Hawighorst, W Weikel, et al. · PubMed · 153
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
1998 · H Hawighorst, P G Knapstein, et al. · PubMed · 142
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
1997 · H Hawighorst, P G Knapstein, et al. · PubMed · 141
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
2014 · G. von Minckwitz, S. Loibl, et al. · Annals of Oncology · 138
Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer
2008 · Marcus Schmidt, Dirk Hasenclever, et al. · Clinical Cancer Research · 82
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer
2022 · Katrin Almstedt, Anne-Sophie Heimes, et al. · European Journal of Cancer · 78
Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015
2016 · H. Schnürch, S. Ackermann, et al. · Geburtshilfe und Frauenheilkunde · 76
PDF
Tumor Vascularity—A Novel Prognostic Factor in Advanced Cervical Carcinoma
1995 · Karlheinz Schlenger, Michael Höckel, et al. · Gynecologic Oncology · 71
Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
1996 · H Hawighorst, P G Knapstein, et al. · Radiology · 68
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
1999 · S Wang-Gohrke, W Weikel, et al. · British Journal of Cancer · 67
Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67
1991 · W. Weikel, T. Beck, et al. · Breast Cancer Research and Treatment · 55
p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
2003 · M. Schmidt, A. Bachhuber, et al. · Journal of Cancer Research and Clinical Oncology · 48
Reconstructive surgery following resection of primary vulvar cancers
2005 · W. Weikel, M. Hofmann, et al. · Gynecologic Oncology · 47
Usefulness of Immunohistochemical Staining for p53 in the Prognosis of Breast Carcinomas: Correlations with Established Prognosis Parameters and with the Proliferation Marker, MIB-1
1995 · T. Beck, E.E. Weller, et al. · Gynecologic Oncology · 45
Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC)
1994 · Thomas Beck, Wolfgang Weikel, et al. · Gynecologic Oncology · 43
Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas
1991 · Roland Moll, Susanne Pitz, et al. · Human Pathology · 43
Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix
1987 · W. Weikel, R. Wagner, et al. · Virchows Archiv B Cell Pathology Including Molecular Pathology · 41
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer
2023 · Katrin Almstedt, Lisa Krauthauser, et al. · Cancers · 40
PDF
Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma
1995 · G. Weber, E. Merz, et al. · Ultrasound in Obstetrics and Gynecology · 40
Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine
2001 · Ignaz Wessler, Elisabeth Roth, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 36
Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing
2005 · Marcus Schmidt, Barbara Lewark, et al. · Breast Cancer Research · 34
PDF
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
2019 · Hans-Georg Schnürch, Sven Ackermann, et al. · Geburtshilfe und Frauenheilkunde · 28
PDF
Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer
2015 · A. Kümmel, S. Kümmel, et al. · Geburtshilfe und Frauenheilkunde · 23
PDF
Urokinase and Plasminogen Activator-Inhibitor (PAI-1) Status in Primary Ovarian Carcinomas and Ovarian Metastases Compared to Benign Ovarian Tumors as A Function of Histopathological Parameters
1999 · Gerald Hoffmann, Kunhard Pollow, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 23
Surgical therapy of recurrent vulvar cancer
2006 · Wolfgang Weikel, Markus Schmidt, et al. · American Journal of Obstetrics and Gynecology · 22
Works count: 107
Citation count: 1,751
H-index: 23
I10-index: 32
Year
Topic
Type